Well one thing's for sure, ADO management scoffed at $1 per test revenue to ADO as completely unrealistic.(Per roadshow reports from Melbourne.)
So what IS a realistic cut? They gave absolutely no indication.
Unless Ellume manages to get colossal numbers of tests, it seems we aren't going to see significant revenue.
The potential rivers of gold for ADO have been batteries for a long time now. Diagnostic testing revenues might be nice.
New Feature Announcement!
We’re excited to introduce the DealRoom portal, now live on site, providing users with exciting access to private equity opportunities for both pre-IPO and publicly listed companies.
See full details by selecting the new menu item named 'DealRoom' on our main menu bar or click below.
Stay ahead of the market, with HotCopper.